Author Correction: The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech) - Université de La Réunion Access content directly
Journal Articles Scientific Reports Year : 2022

Author Correction: The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech)

Fichier principal
Vignette du fichier
s41598-022-10885-7.pdf (663.1 Ko) Télécharger le fichier
Origin Publisher files allowed on an open archive

Dates and versions

hal-04542363 , version 1 (15-04-2024)

Identifiers

Cite

Jessica Andries, Wildriss Viranaicken, Colette Cordonin, Charline Herrscher, Cynthia Planesse, et al.. Author Correction: The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech). Scientific Reports, 2022, 12 (1), ⟨10.1038/s41598-022-10885-7⟩. ⟨hal-04542363⟩
10 View
4 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More